miRNome in myocardial infarction: Future directions and perspective

doi:10.4330/wjc.v6.i9.939

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8983)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

436

WORD

337

HTML

5359

Figures (1-6)

230

Tables (1-2)

207

Sum=6569

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1171

Download

1243

Sum=2414

Sep 26, 2014 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Cardiol. Sep 26, 2014; 6(9): 939-958
Published online Sep 26, 2014. doi: 10.4330/wjc.v6.i9.939

Full Size Figure Download Figure

Figure 5 Therapeutic opportunities of miRNAs in myocardial infarction identified by using mouse model of myocardial infarction. BMC: Bone marrow cell; ESC: Embryonic stem cell; LV: Left ventricle; MSC: Mesenchymal stem cell; MI: Myocardial infarction; IGF-1: Insulin-like growth factor 1.

Citation: Boštjančič E, Glavač D. miRNome in myocardial infarction: Future directions and perspective. World J Cardiol 2014; 6(9): 939-958
URL: https://www.wjgnet.com/1949-8462/full/v6/i9/939.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i9.939